Spain's first EU-GMP indoor cannabis facility.

Medical cannabis flower, grown indoors to EU-GACP and processed to EU-GMP under one roof in Barcelona, by a team that treats EU-GMP as the starting line, not the finish.
Download our EU-GMP certificate PDF ↓ES/109/26 · Issued by AEMPS, September 2026

OUR MISSION


To be Europe's reference indoor producer of medical cannabis flower. Made in the EU, for Europe.
Meeting the specification makes a flower compliant. It does not make it exceptional. Two flowers can share the same certificate and still be very different: what sets them apart is the genetics, and how faithfully terpenes, aroma, structure and texture are preserved from the plant to the pharmacy.

NOT ALL EU-GMP
FLOWER IS EQUAL 



As Europe's medical cannabis market matures, prescribers and pharmacies expect more from flower: the same profile from batch to batch, full documentation and reliable supply over time.

We built Canamedics for that market.
Smaller batches, more frequent releases, and cultivars kept in continuous production for as long as they are needed.

ONE ROOF,
NO SHORTCUTS


Grown indoors to EU-GACP and processed to EU-GMP from drying onwards, in one facility in Barcelona certified by the Spanish Medicines Agency (AEMPS) in September 2026. No flower bought in, reprocessed or re-tested to earn the label.


OUR OWN
CLONES


Identical clones produced in-house from selected breeders, with mother plants renewed in vitro and molecular-marker testing for genetic consistency and stability. Nothing enters or leaves without control.


FEWER HANDS,
MORE CONSISTENCY


People are the main source of error and microbial risk in a grow room. AI-assisted cultivation keeps intervention to a minimum, for a more consistent, repeatable crop.



PROCESS IS
THE PRODUCT 


EU-GMP should be the baseline, not the selling point. What sets a flower apart is how it is made and how well it is preserved, from harvest to the sealed bag.

PHARMA
CRAFT


Cold hang-drying in rooms under 10 m², hand or cryo trimming chosen per cultivar, variety-specific curing, packed under nitrogen.

BEYOND
POTENCY


THC is only one number. We protect the sensory integrity and organoleptic quality of the flower: the terpenes, aroma, structure and texture a routine analysis does not capture.

Indoor · EU-GMP · Barcelona

Made in the EU, for Europe.

Grown, processed and released in Barcelona, for patients across Europe.
1stindoor cannabis facility in Spain certified EU-GMP by the AEMPS, and one of the few in Europe to grow indoors and process to EU-GMP under one roof
0 kmbetween harvest and GMP drying: grown, dried and released at the same EU-GMP site
65–90genuine EU-GMP cannabis sites in the whole world, against some 1,300 GACP operations. We are one of them.
Where European regulators are heading
2022MHRA · United KingdomSupply-chain visibility becomes the priority: the regulator wants to know where every step, drying included, takes place.
2025EMA · European UnionFirst revision of GACP since 2006: indoor growers must define critical process parameters and qualify their equipment.
2026HLfGP · Hesse, GermanyDrying is a critical GMP step, done where the plant is harvested. The authority knows of no process showing that flower can travel long distances without losing quality.
Sources: industry estimate of EU-GMP sites, Krautinvest (Sept 2026); MHRA Inspectorate (Nov 2022); EMA, revised GACP guideline (2025); HLfGP information sheet on GMP requirements for cannabis (June 2026).